CCL20/MIP-3 alpha Antibody (308B7.06)
Novus Biologicals, part of Bio-Techne | Catalog # DDX0431P-100
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Frozen, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # 308B7.06
Concentration
0.5 mg/ml
Product Specifications
Immunogen
MIP-3 Alpha/CCL20 was used as immunogen.
Reactivity Notes
Human
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Scientific Data Images for CCL20/MIP-3 alpha Antibody (308B7.06)
Immunohistochemistry: CCL20/MIP-3 alpha Antibody (308B7.06) [DDX0431P-100]
Immunohistochemistry: CCL20/MIP-3 alpha Antibody (308B7.06) [DDX0431P-100] - Paraffin Bouin human tonsil section:staining with 308B7.06-HRP.Immunohistochemistry: CCL20/MIP-3 alpha Antibody (308B7.06) [DDX0431P-100]
Immunohistochemistry: CCL20/MIP-3 alpha Antibody (308B7.06) [DDX0431P-100] - human tonsil cryosection: staining with308B7.06Applications for CCL20/MIP-3 alpha Antibody (308B7.06)
Application
Recommended Usage
Immunohistochemistry
1:10-1:500
Immunohistochemistry-Frozen
1:10-1:500
Immunohistochemistry-Paraffin
1:10-1:500
Formulation, Preparation, and Storage
Purification
Ion exchange chromatography
Formulation
Tris-NaCl (pH 8.0)
Preservative
No Preservative
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: CCL20/MIP-3 alpha
Alternate Names
exodus-1, LARC, MIP-3 alpha, MIP3 alpha
Gene Symbol
CCL20
Additional CCL20/MIP-3 alpha Products
Product Documents for CCL20/MIP-3 alpha Antibody (308B7.06)
Product Specific Notices for CCL20/MIP-3 alpha Antibody (308B7.06)
This product is manufactured by Eurobio Scientific (formerly Dendritics) and distributed by Novus Biologicals.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...